Form 13-F position report

VISTAGEN THERAPEUTICS INC COM

Reported by ARMISTICE CAPITAL LLC

VTGN CUSIP 92840H400 Manager CIK 0001601086

Reported 300,000 shares, down 64,000 (17.6%) from the prior quarter.

Reported value -45.7%; share count -17.6% vs. the prior quarter.

Reduced
% of reported 13F value 0.01% This manager · Q2 2024
Shares 300,000 Quarter-end amount reported
Reported value $1,044,000 Fair value at quarter end
Consecutive quarters held 3 Through Q2 2024

Reported position value by quarter

Reported position value by quarter

Each bar is a Form 13-F quarter-end snapshot. It does not show trades made within the quarter.

Reported position value by quarter
Date Holding Value
2023-12-31 2456920
2024-03-31 1921920
2024-06-30 1044000
2024-09-30 0

Quarterly position history

How this manager's reported quarter-end position changed over time.

4 quarters
Quarterly reported position history for VISTAGEN THERAPEUTICS INC COM held by ARMISTICE CAPITAL LLC.
Quarter Activity Shares Change % of reported 13F Reported value Filed Source filing
Q3 2024 Reduced 0 -300,000 (-100.0%) 0 $0 2024-11-14
Q2 2024 Reduced 300,000 -64,000 (-17.6%) 0.01% $1,044,000 2024-08-14
Q1 2024 Reduced 364,000 -114,000 (-23.8%) 0.03% $1,921,920 2024-05-15
Q4 2023 New 478,000 +478,000 (0.0%) 0.03% $2,456,920 2024-02-13

Who else reported the position

49 managers reported VISTAGEN THERAPEUTICS INC COM for Q2 2024.

Managers reporting VISTAGEN THERAPEUTICS INC COM in Q2 2024.
Manager Activity Shares Change % of reported 13F Reported value Tenure
BVF INC IL Unchanged 2,000,000 0 0.2% $6,960,000 3 qtrs
VANGUARD GROUP INC Unchanged 1,793,166 0 < 0.01% $6,240,217 5 qtrs
STEMPOINT CAPITAL LP Unchanged 1,848,582 0 1.72% $5,848,164 3 qtrs
COMMODORE CAPITAL LP Unchanged 1,575,000 0 0.37% $5,481,000 4 qtrs
GREAT POINT PARTNERS LLC Reduced 1,529,338 -329,397 1.02% $5,322,096 3 qtrs
Nantahala Capital Management LLC Unchanged 1,517,696 0 0.31% $5,281,582 3 qtrs
SPHERA FUNDS MANAGEMENT LTD Unchanged 808,550 0 0.38% $2,813,754 4 qtrs
CITADEL ADVISORS LLC Reduced 629,645 -114,275 < 0.01% $2,191,164 5 qtrs
BlackRock Inc Added 402,747 +54,309 < 0.01% $1,401,560 5 qtrs
ARMISTICE CAPITAL LLC This report Reduced 300,000 -64,000 0.01% $1,044,000 3 qtrs
Premium adds each manager's conviction percentile across reporting peers.
Filing details and methodology As reported
Report period
June 30, 2024
Filed
August 14, 2024
Filing type
13F-HR
Position type
COM

Voting authority reported

Sole
300,000
Shared
0
None
0

“None” means the manager reported no voting authority for those shares on non-routine matters. It does not disclose why and is not evidence of securities lending.

Form 13-F is a delayed quarter-end snapshot of disclosed long Section 13(f) securities. It can be filed up to 45 days after quarter end, excludes short positions and most non-U.S. securities, and does not reveal intra-quarter trading. For options, reported shares and value describe the underlying-share exposure; strike, expiry, premium, and written positions are not disclosed.